Focal amplification peaks, including the well‐studied cancer‐driven gene MYC (8q.24.21) and several antiapoptotic genes (MCL1, HORMAD1, and ECM1 on 1q21.2), were identified in the high‐risk patients, along with a focal deletion peak at 13q14.2. This evidence concerns the gene ECM1 and cancer.